An experimental treatment from @ConcertPharma for a severe form of hair loss called alopecia areata could restore a nearly full head of hair in up to 40 percent of people, the company said. https://t.co/CqlE3r6KSn
— Boston Globe Technology (@BostonGlobeTech) May 23, 2022
Get the latest Concert Pharmaceuticals Inc (CNCE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.